Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads

MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the company’s Single Molecule, Real-Time (SMRT®) Sequencing technology. Edinburgh Genomics, Oxford Genomics Centre,... Read more

PerkinElmer Launches MaxSignal™ HTS Total Aflatoxins and DON ELISA Kits with Advanced Automation for Streamlined Mycotoxin Testing

Solution designed for complex matrices, delivering high sensitivity, single sample prep and high throughput processing   WHAT:   PerkinElmer , a global leader committed to innovating for a healthier world, today announced its MaxSignal™ HTS Total Aflatoxins and DON ELISA Kits featuring automated Read more

WITec in Japan and the Chiba Institute of Technology, Japan, cooperate to analyze microplastics (< 20 µm)

WITec GmbH, the German manufacturer of high-performance Raman, AFM, SNOM, and correlative nano-analytical microscopy systems, announces a new cooperation in Japan for particle analysis. Dr. Yutaka Kameda, Associate Professor at the Chiba Institute of Technology (CIT) in Japan, and his team have been working very successfully for several years on the analysis of microplastics in... Read more

Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing

SAN DIEGO & WELLESLEY, Mass.–(BUSINESS WIRE)–Illumina, Inc. (Nasdaq: ILMN) and Harvard Pilgrim Health Care announce a risk-sharing agreement to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members, effective January 1, 2021. The program will leverage WGS to support faster diagnoses of genetic diseases in children, potentially eliminating the long, costly diagnostic odyssey experienced... Read more

A new analyser promising to become a craft brewer´s best friend!

In a business with low margins, no one knows better than the craft brewer that time and extract quantity equals money! Driven by the passion for brewing and for analytics, FOSS has answered the call with a great new tool promising to become a game-changer for process optimisation. Monday, November 30, 2020 FOSS proudly presents BeerFoss™... Read more

Think20 Labs Addressing Regulatory Challenges for Pesticides in Cannabis

(Peabody, Mass. And Irvine, Calif. November 19, 2020) JEOL USA, a leading supplier of mass spectrometers, electron microscopes, and NMR spectrometers, began collaborating with Think20 Labs this year to provide improved and more precise analytical techniques to the Cannabis testing market. Think20 Labs is a start-up company based in California that is licensed by the California... Read more

Danaher To Present At Wolfe Research Healthcare Conference

WASHINGTON, Nov. 16, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Wolfe Research Healthcare Conference on Thursday, November 19, 2020 at 12:00 p.m. ET. The audio will be simultaneously webcast on www.danaher.com.  ABOUT DANAHERDanaher is a global science and technology innovator... Read more

Roche ranked the most sustainable healthcare company in the Dow Jones Sustainability Indices for the eleventh time

The ranking acknowledges Roche’s commitment to sustainability as an integral part of its business strategy Roche performed particularly well in Marketing Practices, Environmental and Social Reporting, Operational Eco-Efficiency, Climate Strategy, and Corporate Citizenship and Philanthropy              Basel, 16 November 2020 – For the eleventh time, Roche (SIX: RO, ROG; OTCQX: RHHBY) has been recognised as the... Read more

Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) is further extending the reach of the NextSeq™ 2000 Sequencing System with the commercial availability of the P3 high-output flow cell. The P3 flow cell offers 1.1 billion reads in a single sequencing run, almost three times more than previously available on Illumina’s mid-throughput NextSeq sequencing portfolio, expanding the... Read more

Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit

SAN DIEGO–(BUSINESS WIRE)–. Illumina, Inc. (NASDAQ: ILMN) is further extending the reach of the NextSeq™ 2000 Sequencing System with the commercial availability of the P3 high-output flow cell. The P3 flow cell offers 1.1 billion reads in a single sequencing run, almost three times more than previously available on Illumina’s mid-throughput NextSeq sequencing portfolio, expanding... Read more